Advances in vaccine technology, antibody therapies, and genetic surveillance are giving researchers new tools to fight ...
KAMPALA, Uganda -- The development of the new malaria medicine from the Basel-based pharmaceutical company Novartis for babies weighing 4½ to 11 pounds has given hope to many, with health workers in ...
Switzerland's medical products authority has granted the first approval for a malaria medicine designed for small infants, touted as an advance against a disease that takes hundreds of thousands of ...
NEW YORK (AP) — Researchers on Wednesday reported two promising new approaches to counteract malaria’s growing resistance to medication — one involving a new class of drugs. Switzerland-based Novartis ...
Add Yahoo as a preferred source to see more of our stories on Google. This October 2024 image provided by Novartis shows GanLum, a new anti-malaria treatment, at a manufacturing facility in Slovenia. ...
NEW YORK(AP) — Researchers on Wednesday reported two promising new approaches to counteract malaria’s growing resistance to medication — one involving a new class of drugs. Switzerland-based Novartis ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results